Target intelligence / Profile preview

MT-ND1 pseudogene 19 (MTND1P19)

Target
MTND1P19
Molecular classification
Other (pseudogene)
01

Overview

**MT-ND1 pseudogene 19 (MTND1P19)** is classified as a pseudogene related to the mitochondrial gene MT-ND1, which encodes a core subunit of mitochondrial respiratory chain complex I involved in electron transport[4][6][7]. Pseudogenes such as MTND1P19 do not encode functional proteins due to mutations or incomplete sequences and are generally considered non-functional genomic elements, though some may have regulatory or transcriptional roles in specific contexts. There is no evidence that MTND1P19 is a drug target, involved in biological processes, associated with disease states, or interacts with drugs. The canonical mitochondrial gene, MT-ND1, is important in oxidative phosphorylation and associated with various mitochondrial diseases, but this does not apply to the pseudogene[1][3][5]. **Key notes**: - MTND1P19 is a *nuclear-encoded pseudogene* of the mitochondrial MT-ND1 gene; it does not produce a functional protein[4][6][7]. - It is not referenced as a therapeutic target, biomarker, or having disease relevance in current sources. - There may be confusion with the functional mitochondrial gene MT-ND1, which is a bona fide therapeutic target and biomarker, but MTND1P19 itself does not function in these roles. - Pseudogenes may appear in transcriptomic datasets, but are generally excluded from target/drug discovery efforts unless shown to have functional roles, which has not been established for MTND1P19 in scientific literature to date[8].

Other names
MT-ND1 pseudogene 19MTND1P19mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 pseudogene 19NADH dehydrogenase 1 pseudogene 19

Beyond the preview

Go deeper on MT-ND1 pseudogene 19 (MTND1P19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND1 pseudogene 19 (MTND1P19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call